Physician profile
Christopher R Seaver
NPI 1063672665
$34,817.59
in general payments reported to CMS, 2019-2025
15 companies · $9,297 in 2025
The $9,297 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $292 · 2022: $783 · 2023: $12K · 2024: $12K · 2025: $9,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $22K · Food and Beverage: $7,969 · Travel and Lodging: $3,456 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $22,077.85 |
| Food and Beverage | $7,969.40 |
| Travel and Lodging | $3,456.12 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,555.12 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $3,538.37 | 2021-2025 | Phasix Mesh, Channel Drain |
| Tela Bio, INC. | $1,305.33 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $1,275.81 | 2021-2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Becton, Dickinson and Company | $880.52 | 2024 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $640.73 | 2023-2025 | |
| Smith+Nephew, INC. | $302.16 | 2019-2023 | Stravix Pl, Grafix Pl, Stravix Mesh |
| Intrinsic Therapeutics | $139.41 | 2024 | Barricaid Acd (Annular Closure Device) |
| Dilon Technologies, INC. | $48.52 | 2023 | Hemoblast Bellows |
| Conmed Corporation | $36.61 | 2025 | Airseal |
| Zimmer Biomet Holdings, INC. | $24.72 | 2025 | A.L.P.S. |
| Acell, INC. | $21.55 | 2019 | |
| Integra Lifesciences Corporation | $19.61 | 2022 | |
| Kci USA, INC. | $14.93 | 2019 | |
| Bolder Surgical LLC | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Seaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.